Methylphenidate: Mechanism of action and clinical update

Journal of Child and Adolescent Psychiatric Nursing

Volumn 17, Issue 2, 2004, Pages 85-86

  Scahill, Lawrence ^a   Carroll, Deirdre ^b   Burke, Kathleen ^a  

^a YALE UNIVERSITY   (United States)

^b BOSTON COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT; DOPAMINE RECEPTOR; METHYLPHENIDATE;

ATTENTION DEFICIT DISORDER; CHILD; DRUG EFFECT; FEMALE; HUMAN; MALE; REVIEW;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; FEMALE; HUMANS; MALE; METHYLPHENIDATE; RECEPTORS, DOPAMINE;

EID: 4844221732     PISSN: 10736077     EISSN: 17446171     Source Type: Journal    
DOI: 10.1111/j.1744-6171.2004.00085.x     Document Type: Article

References (10)

1. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed.-text rev.). Washington, DC: Author.
2. Cooper, J.R., Bloom, F.E., & Roth, R.H. (2001). Biochemical basis of neuropsychopharmacology (8th ed.). New York: Oxford University Press.
3. Mannuzza, S., & Klein, R.G. (2000). Long-term prognosis in attentiondeficit/ hyperactivity disorder. Child and Adolescent Psychiatric Clinics of North America, 9, 711-726.
4. The MTA Cooperative Group. (1999). Multimodal treatment study of children with ADHD: A14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 56, 1073-1086.
5. Olfson, M., Gameroff, M.J., Marcus, S.C., & Jensen, P.S. (2003). National trends in the treatment of attention deficit hyperactivity disorder. American Journal of Psychiatry, 160, 1071-1077.
6. Scahill, L., & Schwab-Stone, M. (2000). Epidemiology of attention deficit hyperactivity disorder in school-age children. Child and Adolescent Psychiatric Clinics of North America, 9, 541-555.
7. Solanto, M.V., Arnsten, A.F.T., & Castellanos, F.X. (2001). Stimulant drugs and ADHD: Basic and clinical neuroscience. New York: Oxford University Press.
8. Volkow, N.D., Wang, G.J., Fowler, J.S., Gatley, S.J., Logan, J., Ding, Y.S., & Hitzemann, R. (1998). Dopamine transporter occupancies in the human brain induced by therapeutic doses of methylphenidate. American Journal of Psychiatry, 155, 1325-1321.
9. Volkow, N.D., Wang, G.J., Fowler, J.S., Logan, J., Franceski, D., Maynard, L., et al. (2002). Relationship between blockade of dopamine transporters by oral methylphenidate and the increased in extracellular dopamine: Therapeutic implications. Synapse, 43, 181-187.
10. Volkow, N.D., Wang, G.J., Fowler, J.S., Logan, J., Gerasimov, M., Maynard, L., et al. (2001). Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in human brain. Journal of Neuroscience, 21, 1-5.